HCA: Bullish Pennant detected on 17 Aug 2026

HCA is forming a bullish pennant—a tight consolidation phase after a sharp move, now at $404.68. The pattern shows balanced structure (12/15) and solid breakout potential (13/13), with volume confirmation scoring 12/12. The setup is intermediate quality with a 77/98 overall score and 60.28% win probability. Key support sits at $391.38; resistance at $421.31. Volatility of 3.16% and RSI at 52.06 indicate controlled momentum, neither overbought nor oversold. Volume is trailing at 0.67x average, so confirmation will be critical on breakout.

HCA released Q2 2026 results in late July, reducing full-year earnings guidance as a growing number of uninsured patients weighed on profitability following changes in health insurance exchange coverage, with the shift in patient payer mix impacting second-quarter earnings despite higher revenue and continued growth in patient admissions. Net income guidance was lowered to $6.3–$6.7 billion from $6.495–$7.035 billion, with diluted EPS now $28.70–$30.50 versus prior $29.10–$31.50. HCA estimates insurance exchange coverage changes will reduce full-year earnings by $1.0–$1.2 billion. The guidance cut in mid-July coincides with the consolidation pattern forming, signaling investors are recalibrating expectations after the negative surprise. Healthcare sector remains bullish (regime 0.95), but company-specific headwinds now offset earlier optimism.

A successful pennant breakout above $421.31 resistance would target $434.89 (measured move), roughly 3.2% upside from current levels. Volume confirmation is essential—expect above-average volume (>1.4M shares) on the breakout to validate the move. The 60% win probability reflects moderate conviction; breakouts fail roughly 40% of the time. Invalidation occurs on a close below $391.38 support, which would negate the bullish structure and suggest consolidation has become a distribution pattern instead.

HCA's guidance cut estimated insurance exchange coverage will reduce 2026 earnings by $1.0–$1.2 billion, a material headwind that could pressure margins further if utilization trends worsen. Insider activity shows 7 insider sells in the past 12 months with no purchases, signaling limited confidence from management. HCA Healthcare is facing challenges following recent guidance cuts and union protests, impacting investor sentiment. Beta of 0.73 provides some downside cushion, but volume at 67% of average suggests thin conviction—any negative catalyst could trigger a break below support. Q3 earnings in late October will be critical to monitor for further payer mix deterioration.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.